Abbott's Panbio Rapid Antigen Test Receives CE Mark for Mass COVID-19 Screening
Shots:
- Abbott received a CE mark for asymptomatic testing and self-swabbing using its Panbio COVID-19 Ag test to detect SARS-CoV-2. Abbott has shipped 200M test to 120 countries globally
- The test is approved with a patient-friendly and minimally invasive nasal swab- i.e. patients can self-administer sample collection under an HCP’s supervision and delivers results in 15mins
- The test has demonstrated 93.8% sensitivity & 100% specificity in asymptomatic people with high viral loads. Additionally- Abbott will offer the NAVIC mobile app allowing people to display negative results for proof of testing and Sympheos for surveillance management to understand epidemiological trends
Ref: PRNewswire | Image: abbott
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com